PharmaBlock Sciences (Nanjing), Inc. (300725.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About PharmaBlock Sciences (Nanjing), Inc.
—
PharmaBlock Sciences (Nanjing), Inc. (300725.SZ) stock trades at $43.81 with a market capitalization of $10.29B. The stock is valued at a price-to-earnings (P/E) ratio of 46.35, price-to-book of 2.25, price-to-sales of 4.87. Over the past 52 weeks the stock has ranged between $30.90 and $57.55, and currently trades 23.9% below its 52-week high. It pays a dividend yielding 0.86%.
On profitability, PharmaBlock Sciences (Nanjing), Inc. generates a return on equity (ROE) of 5.14%, an operating margin of 9.16%, a net profit margin of 9.97%.
Official website: www.pharmablock.com
PharmaBlock Sciences (Nanjing), Inc. (300725.SZ) — frequently asked questions
What is PharmaBlock Sciences (Nanjing), Inc. (300725.SZ) stock price today?
PharmaBlock Sciences (Nanjing), Inc. (300725.SZ) is currently trading at $43.81, down 0.39% today.
What is 300725.SZ P/E ratio?
PharmaBlock Sciences (Nanjing), Inc.'s P/E ratio is 46.35. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 300725.SZ return on equity (ROE)?
PharmaBlock Sciences (Nanjing), Inc.'s return on equity (ROE) is 5.14%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is PharmaBlock Sciences (Nanjing), Inc.'s market cap?
PharmaBlock Sciences (Nanjing), Inc. has a market capitalization of $10.29B.
Does 300725.SZ pay a dividend?
Yes. PharmaBlock Sciences (Nanjing), Inc. currently yields 0.86%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 300725.SZ carry?
PharmaBlock Sciences (Nanjing), Inc. has a debt-to-equity ratio of 0.03. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 300725.SZ's profit margin?
PharmaBlock Sciences (Nanjing), Inc. reports a net profit margin of 9.97% — the share of revenue left after every cost, including tax and interest.
What sector is 300725.SZ in?
PharmaBlock Sciences (Nanjing), Inc. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 300725.SZ listed on?
PharmaBlock Sciences (Nanjing), Inc. trades on SHZ under the ticker 300725.SZ.
What is 300725.SZ's 52-week range?
Over the last year PharmaBlock Sciences (Nanjing), Inc. has traded between $30.90 and $57.55.
Related — Stocks
Popular Stocks
Screens 300725.SZ currently matches
On the figures above, PharmaBlock Sciences (Nanjing), Inc. passes the filters for 10 of our ready-made screens, among them Low Debt Stocks, Large Cap Stocks, Debt Free Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.